CL2004000379A1 - Uso de una combinacion farmaceutica de lercanidipina con un bloqueador de los receptores de angiotensina ii, seleccionado de olmesartan, irbesartan, valsartan, telmisartan y losartan, para tratar la hipertension. - Google Patents

Uso de una combinacion farmaceutica de lercanidipina con un bloqueador de los receptores de angiotensina ii, seleccionado de olmesartan, irbesartan, valsartan, telmisartan y losartan, para tratar la hipertension.

Info

Publication number
CL2004000379A1
CL2004000379A1 CL200400379A CL2004000379A CL2004000379A1 CL 2004000379 A1 CL2004000379 A1 CL 2004000379A1 CL 200400379 A CL200400379 A CL 200400379A CL 2004000379 A CL2004000379 A CL 2004000379A CL 2004000379 A1 CL2004000379 A1 CL 2004000379A1
Authority
CL
Chile
Prior art keywords
lercanidipine
olmesartan
telmisartan
irbesartan
valsartan
Prior art date
Application number
CL200400379A
Other languages
English (en)
Inventor
Abraham Leonardi Amede Sartani
Original Assignee
Recordati Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Ireland Ltd filed Critical Recordati Ireland Ltd
Publication of CL2004000379A1 publication Critical patent/CL2004000379A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL200400379A 2003-02-28 2004-02-26 Uso de una combinacion farmaceutica de lercanidipina con un bloqueador de los receptores de angiotensina ii, seleccionado de olmesartan, irbesartan, valsartan, telmisartan y losartan, para tratar la hipertension. CL2004000379A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45086403P 2003-02-28 2003-02-28
US45078203P 2003-02-28 2003-02-28

Publications (1)

Publication Number Publication Date
CL2004000379A1 true CL2004000379A1 (es) 2005-01-21

Family

ID=32930575

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200400379A CL2004000379A1 (es) 2003-02-28 2004-02-26 Uso de una combinacion farmaceutica de lercanidipina con un bloqueador de los receptores de angiotensina ii, seleccionado de olmesartan, irbesartan, valsartan, telmisartan y losartan, para tratar la hipertension.

Country Status (4)

Country Link
AR (1) AR043395A1 (es)
CL (1) CL2004000379A1 (es)
TW (1) TW200501953A (es)
WO (1) WO2004075892A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1812423A1 (en) * 2004-11-11 2007-08-01 LEK Pharmaceuticals D.D. Process for the synthesis of tetrazoles
CN1298389C (zh) * 2005-01-18 2007-02-07 广东省人民医院 一种含替米沙坦和钙离子拮抗剂的复方降压制剂及其应用
WO2008040367A1 (en) * 2006-08-01 2008-04-10 Union Quimico-Farmaceutica S.A. Lercanidipine hydrobromide, a process for its preparation, crystalline forms and compositions thereof
WO2008023869A1 (en) * 2006-08-24 2008-02-28 Hanall Pharmaceutical Co., Ltd. Combined pharmeceutical formulation with controlled-release comprising dihydropyridine calcium channel blockers and hmg-coa reductase inhibitors
US20080175872A1 (en) * 2006-09-28 2008-07-24 Osmotica Corp. Controlled Release Dosage Form Containing Lercanidipine and a Performance-enhancing Acid
KR101247583B1 (ko) * 2006-12-08 2013-03-26 한미사이언스 주식회사 암로디핀 또는 이의 약제학적 허용가능한 염, 및 로자탄또는 이의 약제학적 허용가능한 염을 함유하는 약제학적조성물
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
CN102600146B (zh) * 2012-04-11 2014-10-08 兆科药业（合肥）有限公司 一种盐酸乐卡地平和氯沙坦钾复方制剂及其制备方法
MX2015002169A (es) * 2015-02-18 2016-08-17 Invekra S A P I De C V Composiciones farmaceuticas para el tratamiento de la hipertension con base en una nueva combinacion de farmacos.
MX2015002170A (es) * 2015-02-18 2016-08-17 Invekra S A P I De C V Nuevas composiciones farmaceuticas para el tratamiento de la hipertension.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000027397A1 (en) * 1998-11-06 2000-05-18 Glaxo Group Limited Antihypertensive medicaments containing lacidipine and telmisartan
ITMI20011726A1 (it) * 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato

Also Published As

Publication number Publication date
TW200501953A (en) 2005-01-16
WO2004075892A2 (en) 2004-09-10
WO2004075892A3 (en) 2004-09-30
AR043395A1 (es) 2005-07-27

Similar Documents

Publication Publication Date Title
IS2534B (is) Nítróoxýafleiður lósartans, valsartans, kandesartans, telmisartans, eprósartans og ólmesartans sem angíótensín-II viðtakatálmar til að meðhöndla hjarta- og æðasjúkdóma
AR051618A1 (es) Comprimido bicapa y metodo
ECSP088987A (es) Formas de dosificación sólidas de valsartan, amlodipina, e hidroclorotiazida, y método para elaborarlas
CL2011001091A1 (es) Forma de dosificacion farmaceutica oral solida que comprende en su nucleo nifedipino o nisoldipino y en un revestimiento de manto alrededor del nucleo al menos un antagonista de angiotensina ii y/o al menos un diuretico; procedimiento para su preparacion, util para tratar hipertension.
CL2004000379A1 (es) Uso de una combinacion farmaceutica de lercanidipina con un bloqueador de los receptores de angiotensina ii, seleccionado de olmesartan, irbesartan, valsartan, telmisartan y losartan, para tratar la hipertension.
BRPI0719060A2 (pt) Composto, prodroga, agente farmacêutico, métodos para inibir um receptor de angiotensina ii e/ou ativar um receptor ativado com proliferador de peroxisoma, e para prevenir ou tratar doenças ou condições, e, uso de um composto
DK1854454T3 (da) Fremgangsmåde til fremstilling af amorf telmisartan
ES1060473Y (es) Red de proteccion, especialmente para proteccion frente a la caida de piedras o para aseguramiento de taludes.
HUS1200008I1 (hu) Benzimidazolszármazékok és alkalmazásuk A II receptor antagonistaként
DE602005007447D1 (de) Axiale Verriegelungseinrichtung mit Verriegelungskeil
DE60327316D1 (de) Kombination enthaltend valsartan, amlodipin und hydrochlorothiazid
DK1761519T3 (da) Indolderivater som histaminreceptorantagonister
BRPI0808025A2 (pt) Composto de benzimidazol e uso farmacêutico do mesmo
BRPI0611025A2 (pt) composto, uso de um composto, e, composição farmacêuticamente aceitável
CL2004000545A1 (es) Uso de un antagonista de los receptores de aldosterona y un antagonista de receptores de endotelina para el tratamiento o profilaxis de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopatia y enfermedades cardiovascul
CL2008000360A1 (es) Uso de una composicion que comprende al menos un fungicida derivado de carbamato y al menos un insecticida seleccionado de antagonistas gaba y agonistas/antagonistas del receptor nicotonico para aumentar la fitosanidad de al menos una variedad vegeta
DE60331808D1 (de) Hydraulisch betätigtes Bypass-Ventil
CL2007003483A1 (es) Compuestos derivados de indol-2-il-carbonil-espiro-piperidina, antagonistas del receptor de la v1a; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de hipertension, dismeno
CL2007003613A1 (es) Compuestos nitroderivados, antagonistas del receptor de angiotensina ii; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar hipertension.
DK1874761T3 (da) 4h-1,2,4-triazin-5-on-derivater, fremstilling heraf og anvendelse heraf som alpha-7-nikotin-acetylcholin-receptorer
SE0400611L (sv) Hydraulisk tryckackumulator
ATE374774T1 (de) Substituierte tricyclische benzimidazole
BRPI0816800A2 (pt) Composto, composição farmacêutica, e, uso de um composto.
ZA200709002B (en) Benzimidazole derivative and use as angiotensin II antagonist
ITVE20080006A1 (it) Dispositivo di interconnessione e tenuta idraulica, particolarmente per due conci costruttivi contigui di una struttura edile